1. Alford, F., Bloom, S., Nabarro, J., Hall, R. Besser, G., Coy, D., Kastin, A. and Schally, A. (1974): Glucagon control of fasting glucose in man. Lancet 2, 974–977.
2. Anonymous (1975): Editorial: Glucoreceptors, insulin release and diabetes. Lancet 2, 646–647.
3. Assan, R., Attale, J., Ballerio, G., Girard, J., Hautecouverture, M., Kervran, A., Plouin, P., Slama, G., Soufflet, E., Tchobroutsky, G. and Tiengo, A. (1973): Some aspects of the physiology of glucagon. In: Diabetes. Proceedings of the V111th Congress of the International Diabetes Federation, Brussels, July 15–20, 1973. W. Malaisse, J. Pirart and J. Vallance-Owen, Eds. International Congress Series ICS, Vol. 312, Excerpta Medica, Amsterdam, pp. 144–178.
4. Barnes, A. and Bloom, S. (1976): Pancreatectomized man: a model for diabetes without glucagon. Lancet 1, 219–221.
5. Block, M., Mako, M., Steiner, D. and Rubenstein, A. (1972): Circulating C-peptide immunoreactivity: studies in normal and diabetic patients. Diabetes 2, 1013–1026.